Trump administration will fund new research on controversial psychedelic drug ibogaine ↗
Federal officials say there's new funding to study the medical potential of a powerful psychedelic. The effort announced Thursday includes nearly $5 million to lay the groundwork for U.S. studies of ibogaine. Ibogaine is made from an African plant and can cause intense hallucinations, nausea, tremors and dangerous heart rhythms. It's currently illegal in the United States.